The apparent calibre and positioning of Alan and Rohan impresses me.
While I have confidence in this team to manage commercialisation features, niche focus and support, in an extensive business life I have yet to be impressed by the sales skills of highly qualified engineeers, chemists and most CEO's when introducing their offering to multi-nationals. I'm sure Pharma may harbour even more layers to penetrate than most industries.
Two or three third party highly respected industry Consultants operating within their niche that has satisfied themselves with all claims and believes in the PYC offering appeals to me. In that interest I did take the time to write to Stephanie with examples of past experiences that brought lightning success out of a torrid struggle to gain execution of that signature.
GLTA
PYC Price at posting:
3.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)